The court appears to note that one problem with this additional invention is that the specification was not very specific.  The claimed “digital data bus”, for instance, is not expressly discussed in the specification other than an oblique reference to “lines carrying the normal wall control switch signals.”

Apple's iMessage infringes on the '801 patent because, like nearly all smartphones, it incorporates support for clickable links in SMS messages. The complaint goes on to argue patent eligibility, though the cited cases appear to be generic and only tangentially related to Hypertext's owned IP.

Although § 145 proceedings are quite rare, the Court's decision is important in preserving them as an option under any circumstances.  Applicants often appeal under § 141 not only because the record may be complete, but also because it is quicker and less costly.  

In a statement sent to WIPR, a Nokia spokesperson said: "Nokia is encouraged that Daimler and several of its tier 1 suppliers have agreed to independent mediation regarding our licensing dispute.”

Juno Therapeutics, now part of Bristol-Myers Squibb, is hoping to prove that Gilead’s Kite Pharma unit is infringing a patent with its blood cancer therapy Yescarta. And the two sides got their chance to air their arguments in court this week.